• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泼尼松龙在肥胖男性体内的处置情况。

Prednisolone disposition in obese men.

作者信息

Milsap R L, Plaisance K I, Jusko W J

出版信息

Clin Pharmacol Ther. 1984 Dec;36(6):824-31. doi: 10.1038/clpt.1984.263.

DOI:10.1038/clpt.1984.263
PMID:6499362
Abstract

Obesity is accompanied by altered secretion and disposition of sex and glucocorticoid hormones, including cortisol, and also confounds parameter normalization and drug dosage selection relative to body weight. Prednisolone disposition was assessed in eight obese and four normal male subjects after a dose of 33 mg iv. Steroid concentrations were determined by HPLC. Kinetics were related to ideal body weight (IBW) and total body weight (TBW). Uncorrected steady-state volume of distribution (Vss) of total prednisolone was 20% greater in obese subjects (36.7 and 44.1 l). This effect could be described by the relationship: Vss = 0.54 IBW + 0.09(TBW-IBW), with a distribution coefficient of 0.09 reflecting limited prednisolone uptake by fat. Protein binding parameters and albumin and transcortin concentrations were similar between groups. Uncorrected total and free prednisolone clearances (Cl) were increased in obesity (11.1 and 8.3 l/hr total; 65.4 and 46.5 l/hr free). Free prednisolone Cl correlated strongly (r = 0.80) with degree of obesity expressed as TBW/IBW. In the obese, endogenous cortisol concentrations were initially higher before exogenous steroid dosing, were suppressed at an identical rate, and returned to baseline more slowly than in normal subjects. The apparent hypersensitivity of the adrenal gland offsets the increased Cl of free prednisolone in obesity, indicating that weight-proportional dosage adjustments of this steroid in obesity should reflect TBW.

摘要

肥胖与包括皮质醇在内的性激素和糖皮质激素的分泌及分布改变有关,并且在根据体重进行参数标准化和药物剂量选择方面也存在混淆。对8名肥胖男性和4名正常男性受试者静脉注射33 mg剂量的泼尼松龙后,评估其处置情况。通过高效液相色谱法测定类固醇浓度。动力学与理想体重(IBW)和总体重(TBW)相关。肥胖受试者中未校正的泼尼松龙总稳态分布容积(Vss)比正常受试者大20%(分别为36.7升和44.1升)。这种效应可用以下关系描述:Vss = 0.54 IBW + 0.09(TBW - IBW),分布系数0.09反映了泼尼松龙在脂肪中的摄取受限。两组之间的蛋白质结合参数以及白蛋白和转皮质素浓度相似。肥胖者中未校正的泼尼松龙总清除率和游离清除率(Cl)均增加(总清除率分别为11.1升/小时和8.3升/小时;游离清除率分别为65.4升/小时和46.5升/小时)。游离泼尼松龙Cl与以TBW/IBW表示的肥胖程度密切相关(r = 0.80)。在肥胖者中,外源性类固醇给药前内源性皮质醇浓度最初较高,以相同速率被抑制,且恢复到基线的速度比正常受试者慢。肾上腺的明显超敏反应抵消了肥胖者中游离泼尼松龙Cl的增加,这表明肥胖者中该类固醇按体重比例进行剂量调整时应反映TBW。

相似文献

1
Prednisolone disposition in obese men.泼尼松龙在肥胖男性体内的处置情况。
Clin Pharmacol Ther. 1984 Dec;36(6):824-31. doi: 10.1038/clpt.1984.263.
2
Theophylline disposition in obesity.肥胖患者体内茶碱的处置情况
Clin Pharmacol Ther. 1978 Apr;23(4):438-44. doi: 10.1002/cpt1978234438.
3
Procainamide disposition in obesity.肥胖人群中普鲁卡因胺的处置情况
Drug Intell Clin Pharm. 1983 Jul-Aug;17(7-8):516-22. doi: 10.1177/106002808301700704.
4
Alterations in prednisolone disposition as a result of oral contraceptive use and dose.口服避孕药的使用及剂量对泼尼松龙处置的影响。
Br J Clin Pharmacol. 1984 Jun;17(6):655-64. doi: 10.1111/j.1365-2125.1984.tb02400.x.
5
Obesity, sex, and acetaminophen disposition.肥胖、性别与对乙酰氨基酚的处置
Clin Pharmacol Ther. 1982 Jun;31(6):783-90. doi: 10.1038/clpt.1982.111.
6
Endogenous and exogenous glucocorticoids in cushingoid patients.库欣综合征患者体内的内源性和外源性糖皮质激素。
Drug Intell Clin Pharm. 1982 Nov;16(11):863-8. doi: 10.1177/106002808201601109.
7
Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.泼尼松龙在肥胖大鼠体内的药代动力学和药效学
J Pharmacol Exp Ther. 1989 Sep;250(3):963-70.
8
Prednisolone disposition and protein binding in oral contraceptive users.
J Clin Endocrinol Metab. 1983 Apr;56(4):702-9. doi: 10.1210/jcem-56-4-702.
9
Obesity effects on nitrazepam disposition.肥胖对硝西泮处置的影响。
Br J Clin Pharmacol. 1986 Nov;22(5):551-7. doi: 10.1111/j.1365-2125.1986.tb02934.x.
10
Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.成人中甲基泼尼松龙与泼尼松龙的药代动力学与剂量的关系
Eur J Clin Pharmacol. 1986;30(3):323-9. doi: 10.1007/BF00541537.

引用本文的文献

1
Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects.肥胖与新冠肺炎的关系:主要药物学方面的综述。
Curr Pharm Biotechnol. 2024;25(13):1651-1663. doi: 10.2174/0113892010264503231108070917.
2
The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach.HPA 轴昼夜节律时间的生理和药理学意义:一种数学建模方法。
J Pharm Sci. 2024 Jan;113(1):33-46. doi: 10.1016/j.xphs.2023.08.005. Epub 2023 Aug 18.
3
Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis.
危重症肥胖患者的药物剂量:关注用于血流动力学支持和预防的药物。
Crit Care. 2021 Feb 23;25(1):77. doi: 10.1186/s13054-021-03495-8.
4
Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.涉及非线性血浆和组织结合的基于生理学的药代动力学模型:在大鼠中泼尼松龙和泼尼松的应用。
J Pharmacol Exp Ther. 2020 Nov;375(2):385-396. doi: 10.1124/jpet.120.000191. Epub 2020 Sep 3.
5
Modern pharmacological treatment of obese patients.肥胖患者的现代药物治疗。
Ther Adv Endocrinol Metab. 2020 Jan 22;11:2042018819897527. doi: 10.1177/2042018819897527. eCollection 2020.
6
Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children.儿科肥胖症中的药物剂量选择:最常开给儿童的药物的现有信息。
Paediatr Drugs. 2019 Oct;21(5):357-369. doi: 10.1007/s40272-019-00352-8.
7
Glucocorticoid Treatment of Symptomatic Sarcoidosis in 2 Morbidly Obese Patients.两名病态肥胖患者症状性结节病的糖皮质激素治疗
Fed Pract. 2019 Jan;36(1):36-40.
8
Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.糖尿病稳定期肾移植受者中总泼尼松和泼尼松龙以及游离泼尼松和泼尼松龙的药代动力学
Ther Drug Monit. 2014 Aug;36(4):448-55. doi: 10.1097/FTD.0000000000000045.
9
Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.在实体器官移植中,泼尼松龙和泼尼松的临床药代动力学和药效学。
Clin Pharmacokinet. 2012 Nov;51(11):711-41. doi: 10.1007/s40262-012-0007-8.
10
Steroids in kidney transplant patients.肾移植患者的类固醇治疗。
Semin Immunopathol. 2011 Mar;33(2):157-67. doi: 10.1007/s00281-011-0259-7. Epub 2011 Feb 18.